| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/27/2008 | WO2008036642A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/27/2008 | WO2008036579A1 Thiazole pyrazolopyrimidines as crf1 receptor antagonists |
| 03/27/2008 | WO2008036541A1 Thiophene pyrazolopyrimidine compounds |
| 03/27/2008 | WO2008036448A2 Composition and method of treating a sore throat |
| 03/27/2008 | WO2008036429A1 Gallium compositions for the treatment of liver cancer and methods of use |
| 03/27/2008 | WO2008036420A2 9-(heteroaryl)-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents |
| 03/27/2008 | WO2008036410A2 Methods and compositions for treating amyotrophic lateral sclerosis (als) |
| 03/27/2008 | WO2008036379A2 Serine hydrolase inhibitors |
| 03/27/2008 | WO2008036377A2 Novel triclosan salts |
| 03/27/2008 | WO2008036353A2 Omega-3 diglyceride emulsions |
| 03/27/2008 | WO2008036316A2 Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 03/27/2008 | WO2008036312A1 Fungicidal methods using immune response modifier compounds |
| 03/27/2008 | WO2008036294A2 Nos inhibitors for treatment of motor deficit disorders |
| 03/27/2008 | WO2008036293A1 Pulmonary surfactant formulations and methods for promoting mucus clearance |
| 03/27/2008 | WO2008036292A2 Method for treating otitis externa |
| 03/27/2008 | WO2008036286A1 Crystalline rosuvastatin calcium |
| 03/27/2008 | WO2008036282A1 Upregulating activity or expression of bdnf to mitigate cognitive impairment in asymptomatic huntington's subjects |
| 03/27/2008 | WO2008036277A1 Pyraz0l0(l,5-a) (1, 3, 5) triazine and pyrazolo (1, 5-a) pyrimidine derivatives useful as protein kinase inhibitors |
| 03/27/2008 | WO2008036272A1 HETEROCYCLIC INHIBITORS OF c-MET AND USES THEREOF |
| 03/27/2008 | WO2008036254A2 Autophagic compounds and tyrosine kinase inhibitors for treating cancer |
| 03/27/2008 | WO2008036247A1 Renin inhibitors |
| 03/27/2008 | WO2008036239A2 Use of lxr agonists for the treatment of osteoarthritis |
| 03/27/2008 | WO2008036216A1 Piperidine derivatives as renin inhibitors |
| 03/27/2008 | WO2008036211A1 Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety |
| 03/27/2008 | WO2008036201A1 Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety |
| 03/27/2008 | WO2008036168A2 New small molecule inhibitors of mdm2 and the uses thereof |
| 03/27/2008 | WO2008036139A2 Inhibitors of mshc and homologs thereof, and methods of identifying same |
| 03/27/2008 | WO2008036067A2 Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents |
| 03/27/2008 | WO2008036046A1 IMIDAZO[l,2-a]PYRIDINE HYDROXYMATE COMPOUNDS THAT ARE INHIBITORS OF HISTONE DEACETYLASE |
| 03/27/2008 | WO2008036022A1 Tetrahydro-lh-pyrido[3,4-b] indole derivatives as cb1 receptor ligands |
| 03/27/2008 | WO2008036021A1 Tetrahydro-lh-pyrido [3,4 -b] indole derivatives as cbl receptor ligands |
| 03/27/2008 | WO2008035998A1 Medicinal composition for inhibiting propagation of human immunodeficiency virus |
| 03/27/2008 | WO2008035982A1 COMBINATION OF A GLUCOCORTICOID AND A β-CYCLODEXTRIN CONJUGATED VITAMIN A DERIVATE COMPLEX |
| 03/27/2008 | WO2008035956A1 New benzoxazole derivative, process for the preparation thereof and pharmaceutical composition comprising the same |
| 03/27/2008 | WO2008035922A1 A composition comprising glucosamine and derivatives thereof and a method for treatment of conjuctivitis using the same |
| 03/27/2008 | WO2008035823A1 Cell death inhibitor |
| 03/27/2008 | WO2008035757A1 Jelly-like food containing ubiquinol |
| 03/27/2008 | WO2008035726A1 Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same |
| 03/27/2008 | WO2008035692A1 Cancer cell identification marker and cancer cell proliferation inhibitor |
| 03/27/2008 | WO2008035686A1 Agent for improving insulin resistance |
| 03/27/2008 | WO2008035629A1 Pyrazolopyrimidine derivative |
| 03/27/2008 | WO2008035604A1 Composition for amelioration of brain function |
| 03/27/2008 | WO2008035535A1 Capsule including antibacterial agent and artificial joint having the capsule attached thereto |
| 03/27/2008 | WO2008035461A1 Postoperative adjuvant chemotherapy for gastric cancer |
| 03/27/2008 | WO2008035373A2 Highly pure polysialic acid and process for preperation thereof |
| 03/27/2008 | WO2008035359A2 Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives |
| 03/27/2008 | WO2008035356A2 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
| 03/27/2008 | WO2008035306A1 3 -amino- pyridine derivatives for the treatment of metabolic disorders |
| 03/27/2008 | WO2008035239A1 Phenyl derivatives and their use as immunomodulators |
| 03/27/2008 | WO2008035209A2 Quinoline and quinazoline derivatives as inhibitors of protein tyrosine kinase activity |
| 03/27/2008 | WO2008035208A2 The use of polymethoxyflavones for the non apoptotic inhibition of cancer cell growth |
| 03/27/2008 | WO2008035195A1 Benzimidazole derivatives as selective acid pump inhibitors |
| 03/27/2008 | WO2008035157A1 Azetidine derivatives as muscarinic receptor antagonists |
| 03/27/2008 | WO2008035128A1 Pharmaceutical compositions containing rosuvastatin calcium |
| 03/27/2008 | WO2008035109A1 Rifaximin |
| 03/27/2008 | WO2008035049A1 Adamantanyl-(cyclopropyl)-ketones as metabotropic glutamate receptor modulators |
| 03/27/2008 | WO2008035023A1 Polymorphs of rimonabant |
| 03/27/2008 | WO2008035001A2 Composition for the treatment of amyotrophic lateral sclerosis |
| 03/27/2008 | WO2008034974A1 2-ARYL-6-PHENYLIMIDAZO[1,2-α]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF |
| 03/27/2008 | WO2008034912A2 Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof |
| 03/27/2008 | WO2008034910A1 Treatment of pain using satraplatin |
| 03/27/2008 | WO2008034909A2 Second line treatment of metastatic hormone refractory prostate cancer using satraplatin |
| 03/27/2008 | WO2008034908A2 Use of vitamin d compounds for the prevention of adhesions |
| 03/27/2008 | WO2008034895A2 Ansamycin derivatives |
| 03/27/2008 | WO2008034891A2 Novel genes related to glutaminyl cyclase |
| 03/27/2008 | WO2008034866A2 Dbait and uses thereof |
| 03/27/2008 | WO2008034863A2 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 03/27/2008 | WO2008034860A1 Pyrrolo[2, 3-b]pyridin-4-yl-benzenesulfonamide compounds as ikk2 inhibitors |
| 03/27/2008 | WO2008034859A1 Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 03/27/2008 | WO2008034832A1 Compositions comprising a statin and caffeine for the treatment of viral infection |
| 03/27/2008 | WO2008034819A1 Injectable pharmaceutical nimesulide solutions |
| 03/27/2008 | WO2008034815A1 Combination of nmda- receptor ligand and a compound with 5-ht6 receptor affinity |
| 03/27/2008 | WO2008034781A1 Cysteine protease inhibitor salt |
| 03/27/2008 | WO2008034776A1 Method for treating cancer harboring egfr mutations |
| 03/27/2008 | WO2008034735A2 4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivatives |
| 03/27/2008 | WO2008034731A1 Octahydropyrrolo [3, 4-c] pyrrole derivatives an their use as antiviral agents |
| 03/27/2008 | WO2008034644A2 Process for making anastrozole |
| 03/27/2008 | WO2008034628A1 Aripiprazole hemifumarate and process for its preparation |
| 03/27/2008 | WO2008034621A2 Nucleotide phosphorylase for the prophylaxis, treatment or diagnosis of acute lung injury (ali) |
| 03/27/2008 | WO2008034608A1 The death receptor cd95 controls neurogenesis of adult neural stem cells in vivo and in vitro |
| 03/27/2008 | WO2008034600A1 Pyrrole derivatives useful for the treatment of cytokine-mediated diseases |
| 03/27/2008 | WO2008034579A1 2-heterocyclyl-5-phenoxymethylpyridine derivatives as anticancer agents |
| 03/27/2008 | WO2008034535A1 Method for treating skin by administering an agent that decreases gmcsf release from keratinocytes |
| 03/27/2008 | WO2008034534A1 3-cyano-5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseases |
| 03/27/2008 | WO2008034516A1 Antibiotic maduraphthalazin salts with delayed release of the active substance and their use |
| 03/27/2008 | WO2008034346A1 Composition and method for treating tumor |
| 03/27/2008 | WO2008034328A1 New use of ginsenoside compound-k in manufacturing medicaments |
| 03/27/2008 | WO2008034316A1 Compound preparation capable of reducing oxidative stress rapidly and the preparative method thereof |
| 03/27/2008 | WO2008034244A1 The combination of a cyclohexanehexol and a nsaid for the treatment of neurodegenerative diseases |
| 03/27/2008 | WO2008034238A1 Methods for producing pure amino acid chelate complexes, and uses thereof |
| 03/27/2008 | WO2008034202A2 Use of ivermectin and derivates thereof for the treatment of amyotrophic lateral sclerosis |
| 03/27/2008 | WO2008034176A1 Cross-linked polysaccharide gels |
| 03/27/2008 | WO2008021928A3 Hepatitis c virus inhibitors |
| 03/27/2008 | WO2008019047A3 Reversible inhibition of sperm receptor synthesis for contraception |
| 03/27/2008 | WO2008016884A3 Soluble epoxide hydrolase inhibitors |
| 03/27/2008 | WO2008013962A9 Method and mixture for in-vivo photochemical cross-linking of collagen |
| 03/27/2008 | WO2008013622A3 Fungicidal azocyclic amides |
| 03/27/2008 | WO2008012563A3 Use of cdk inhibitors for the treatment of granulocyte mediated disorders |
| 03/27/2008 | WO2008012474A3 Pharmaceutical compositions of active substances difficult to improperly divert from their intended route of administration |
| 03/27/2008 | WO2008012107A3 Use of polyethylene glycol in inflammatory skin conditions and wound healing |